Product Details

TREVICTA 175mg prolonged release suspension for injection#

Paliperidone palmitate
175mg
Suspension for injection

ROA

Intramuscular

Applicant Name

J & J Company West Africa Limited

NRN

A4-100554

Status

Active


Composition

 

ATC Code

N05AX13  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 X 1  

Product Description

49 NF-PP-268978 TREVICTA 175mg prolonged release suspension for injection Paliperidone palmitate Each prefilled syringe contains 273 mg paliperidone palmitate equivalent to 175 mg paliperidone. Excipients include Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100554 Drugs Imported Products 1*1 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium

Manufacturer Name

Janssen Pharmaceutica NV

Manufacturer Country

BELGIUM  

Approval Date

2023-10-31  

Expiry Date

2028-10-30